title: Single daily tobramycin dosing in cystic fibrosis: is it better for the patients or the bugs?
authors.affiliation: Pharmacy Department, Bronson Methodist Hospital, Kalamazoo, MI 49007, USA. vandenbh@bronsonhg.org
authors.forename: Heather L
authors.initials: HL
authors.lastname: Vandenbussche
authors.forename: Michael E
authors.initials: ME
authors.lastname: Klepser
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D002648:Child; D002908:Chronic Disease; D003550:Cystic Fibrosis / Q000150:complications / Q000382:microbiology* / Q000503:physiopathology; D004334:Drug Administration Schedule; D006801:Humans; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D014031:Tobramycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics
chemical_list: D000900:Anti-Bacterial Agents; D014031:Tobramycin